Griseofulvin Oral Suspension
- Product NDC
- 80432-056
- 11-digit product format
- 804320056
- Labeler code
- 80432
- Product ID
- 80432-056_f1ea506d-0062-7849-e053-2995a90a94ea
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Griseofulvin Oral Suspension
- Dosage form
- SUSPENSION
- Route
- ORAL
- Labeler
- TriRx Huntsville Pharmaceutical Services LLC
- Application
- ANDA065438
- Marketing category
- ANDA
- Marketing start
- 2022-08-09
- Marketing end
- 0000-00-00
- Substance
- GRISEOFULVIN
- Active strength
- 125 mg/5mL
- Pharmacologic classes
- Decreased Mitosis [PE], Microtubule Inhibition [PE], Tubulin Inhibiting Agent [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2024-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 80432-056-11 | 80432005611 | 118 mL in 1 BOTTLE (80432-056-11) | 118 ml | 2022-08-09 | 0000-00-00 | No | No | Current |